Weekly chemotherapy using PMitCEBO in the palliation of recurrent non- Hodgkin's lymphoma

Acta Oncologica

Volumn 36, Issue 6, 1997, Pages 573-576

  Hoskin, Peter J ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CLINICAL ARTICLE; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; RECURRENT CANCER; STEM CELL;

EID: 0030810280     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709001318     Document Type: Article

References (6)

1. Johnson PWM, Rohatiner AZS, Whelan CGA, et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol 1995; 13: 140-7.
2. Vose JM. Treatment for non-Hodgkin's lymphoma in relapse - what are the alternatives? N Engl J Med 1995; 333: 1565-6.
3. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002-6.
4. Linch DC, Vaughan Hudson B, Hancock BW, et al. A randomized comparison of a third-generation regimen (PACE-BOM) with a standard regimen (CHOP) in patients with histologically aggressive non- Hodgkin's lymphoma: a British National Lymphoma Investigation report. Br J Cancer 1996; 74: 318-22.
5. Kaplan EI, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc [date?]; 53: 457.
6. De Lord C, Newland AC, Linch DC, Vaughan Hudson B, Vaughan Hudson G. Failure of IMVP-16 as second-line treatment for relapsed or refractory high grade non-Hodgkin's lymphoma. Hematological Oncol 1992; 10: 81-86.